Advertisement

NKG2D in Innate and Adaptive Immunity

  • Lewis L. Lanier
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 560)

Abstract

The term “NK receptors” has been applied to a growing number of cell surface receptors that were initially identified by their expression on NK cells. However, it is becoming increasingly obvious that few or none of the known “NK receptors” are completely restricted in expression to NK cells. For example, many of the inhibitory mouse Ly49 receptors were in fact originally cloned from T cell lines [1],[2], the NKR-PI [3],[4] and CD94/NKG2A receptors are found on subsets of both human and mouse T cells [5][7], and KIR have been identified on human T cells [8],[9]. Typically, these “NK receptors” are present on effector or memory T cells, most frequently on γδ-TcR+ T cells or CD8+ T cells, and are rarely observed on naive resting T cells. Thus, the expression of “NK receptors” on T cells implies a role in adaptive, as well as innate, immunity.

Keywords

Natural Killer Cell Natural Killer Cell Cytotoxicity NKG2D Ligand NKG2D Receptor Natural Killer Gene Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

5. References

  1. 1.
    Yokoyama, W.M., L.B. Jacobs, O. Kanagawa, E.M. Shevach, and D.I. Cohen. 1989. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143:1379–1386.PubMedGoogle Scholar
  2. 2.
    Chan, P.-Y., and F. Takei. 1989. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J. Immunol. 142:1727–1736.PubMedGoogle Scholar
  3. 3.
    Ballas, Z.K., and W. Rasmussen. 1990. NK1.1+ thymocytes: Adult murine CD4-,CD8-thymocytes contain an NK1.1+, CD3+, CD5hl, CD44hl, TCR-Vβ8+ subset. J. Immunol. 145:1039–1045.PubMedGoogle Scholar
  4. 4.
    Lanier, L.L., C. Chang, and J.H. Phillips. 1994. Human NKR-P1A: A disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153:2417–2428.PubMedGoogle Scholar
  5. 5.
    Aramburu, J., M.A. Balboa, A. Ramirez, A. Silva, A. Acevedo, F. Sanchez-Madrid, M.O. DeLandazuri, and M. Lopez-Botet. 1990. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 144:3238–3247.PubMedGoogle Scholar
  6. 6.
    Mingari, M.C., M. Ponte, S. Bertone, F. Schiavetti, C. Vitale, R. Bellomo, A. Moretta, and L. Moretta. 1998. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin-15-induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells. Proc. Natl. Acad. Sci. USA 95:1172–1177.PubMedCrossRefGoogle Scholar
  7. 7.
    McMahon, C.W., and D.H. Raulet. 2001. Expression and function of NK cell receptors in CD8(+) T cells. Curr Opin Immunol 13:465–470.PubMedCrossRefGoogle Scholar
  8. 8.
    Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M.C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24:2294–2298.PubMedCrossRefGoogle Scholar
  9. 9.
    Phillips, J.H., J.E. Gumperz, P. Parham, and L.L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403–405.PubMedCrossRefGoogle Scholar
  10. 10.
    Yokoyama, W.M., and B.F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3:304–316.PubMedCrossRefGoogle Scholar
  11. 11.
    Iizuka, K., O.V. Naidenko, B.F. Plougastel, D.H. Fremont, and W.M. Yokoyama. 2003. Genetically linked C-type lectin-related ligands for the NKRPl family of natural killer cell receptors. Nat Immunol. Google Scholar
  12. 12.
    Wu, J., Y. Song, A.B.H. Bakker, S. Bauer, V. Groh, T. Spies, L.L. Lanier, and J.H. Phillips, 1999. An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10. Science 285:730–732.PubMedCrossRefGoogle Scholar
  13. 13.
    Billadeau, D.D., J.L. Upshaw, R.A. Schoon, C.J. Dick, and P.J. Leibson. 2003. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol 4:557–564.PubMedCrossRefGoogle Scholar
  14. 14.
    Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 3:1142–1149.PubMedCrossRefGoogle Scholar
  15. 15.
    Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–730.PubMedCrossRefGoogle Scholar
  16. 16.
    Jamieson, A.M., A. Diefenbach, C.W. McMahon, N. Xiong, J.R. Carlyle, and D.H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17:19–29.PubMedCrossRefGoogle Scholar
  17. 17.
    Bahram, S., M. Bresnahan, D.E. Geraghty, and T. Spies. 1994. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 91:6259–6263.PubMedCrossRefGoogle Scholar
  18. 18.
    Cosman, D., J. Mullberg, C.L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N.J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–133.PubMedCrossRefGoogle Scholar
  19. 19.
    Jan Chalupny, N., C.L. Sutherland, W.A. Lawrence, A. Rein-Weston, and D. Cosman. 2003. ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305:129–135.PubMedCrossRefGoogle Scholar
  20. 20.
    Radosavljevic, M., and S. Bahram. 2003. In vivo immunogenetics: from MIC to RAET1 loci. Immunogenetics 55:1–9.PubMedGoogle Scholar
  21. 21.
    Cerwenka, A., and L.L. Lanier. 2003. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 61:335–343.PubMedCrossRefGoogle Scholar
  22. 22.
    Radaev, S., and P.D. Sun. 2003. Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 32:93–114.PubMedCrossRefGoogle Scholar
  23. 23.
    Cerwenka, A., J.L. Baron, and L.L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 98:11521–11526.PubMedCrossRefGoogle Scholar
  24. 24.
    Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165–171.PubMedCrossRefGoogle Scholar
  25. 25.
    Karre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675–678.PubMedCrossRefGoogle Scholar
  26. 26.
    Hayakawa, Y., J.M. Kelly, J.A. Westwood, P.K. Darcy, A. Diefenbach, D. Raulet, and M.J. Smyth. 2002. Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin. J Immunol 169:5377–5381.PubMedGoogle Scholar
  27. 27.
    Girardi, M., D.E. Oppenheim, C.R. Steele, J.M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R.E. Tigelaar, and A.C. Hayday. 2001. Regulation of Cutaneous Malignancy by gamma delta T Cells. Science.Google Scholar
  28. 28.
    Pende, D., P. Rivera, S. Marcenaro, C.C. Chang, R. Biassoni, R. Conte, M. Kubin, D. Cosman, S. Ferrone, L. Moretta, and A. Moretta. 2002. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62:6178–6186.PubMedGoogle Scholar
  29. 29.
    Lodoen, M., K. Ogasawara, J.A. Hamerman, H. Arase, J.P. Houchins, E.S. Mocarski, and L.L. Lanier. 2003. NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules. J Exp Med 197:1245–1253.PubMedCrossRefGoogle Scholar
  30. 30.
    Krmpotic, A., D.H. Busch, I. Bubic, F. Gebhardt, H. Hengel, M. Hasan, A.A. Scalzo, U.H. Koszinowski, and S. Jonjic. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3:529–535.PubMedCrossRefGoogle Scholar
  31. 31.
    Vales-Gomez, M., H. Browne, and H.T. Reyburn. 2003. Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol 4:4.PubMedCrossRefGoogle Scholar
  32. 32.
    Wu, J., N.J. Chalupny, T.J. Manley, S.R. Riddell, D. Cosman, and T. Spies. 2003. Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein. J Immunol 170:4196–4200.PubMedGoogle Scholar
  33. 33.
    Rolle, A., M. Mousavi-Jazi, M. Eriksson, J. Odeberg, C. Soderberg-Naucler, D. Cosman, K. Karre, and C. Cerboni, 2003. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 171:902–908.PubMedGoogle Scholar
  34. 34.
    Dunn, C., N.J. Chalupny, C.L. Sutherland, S. Dosch, P.V. Sivakumar, D.C. Johnson, and D. Cosman. 2003. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197:1427–1439.PubMedCrossRefGoogle Scholar
  35. 35.
    Jinushi, M., T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi, T. Suzuki, Y. Sasaki, and N. Hayashi. 2003. Critical Role of MHC Class I-Related Chain A and B Expression on IFN-alpha-Stimulated Dendritic Cells in NK Cell Activation: Impairment in Chronic Hepatitis C Virus Infection. J Immunol 170:1249–1256.PubMedGoogle Scholar
  36. 36.
    Tieng, V., C. Le Bouguenec, L. du Merle, P. Bertheau, P. Desreumaux, A. Janin, D. Charron, and A. Toubert. 2002. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A 99:2977–2982.PubMedCrossRefGoogle Scholar
  37. 37.
    Das, H., V. Groh, C. Kuijl, M. Sugita, C. T. Morita, T. Spies, and J.F. Bukowski. 2001. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15:83–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Hamerman, J.A., K. Ogasawara, and L.L. Lanier. 2004. Cutting Edge: Toll-Like Receptor Signaling in Macrophages Induces Ligands for the NKG2D Receptor. J Immunol 172.Google Scholar
  39. 39.
    Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by turnor cells and activation of NK cells and macrophages. Nature Immunology 1:119–126.PubMedCrossRefGoogle Scholar
  40. 40.
    Groh, V., R. Rhinehart, J. Randolph-Habecker, M.S. Topp, S.R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2:255–260.PubMedCrossRefGoogle Scholar
  41. 41.
    Roberts, A.I., L. Lee, E. Schwarz, V. Groh, T. Spies, E.C. Ebert, and B. Jabri. 2001. Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167:5527–5530.PubMedGoogle Scholar
  42. 42.
    Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734–738.PubMedCrossRefGoogle Scholar
  43. 43.
    Castriconi, R., C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2003. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritie cells. Proc Natl Acad Sci U S A 100:4120–4125.PubMedCrossRefGoogle Scholar
  44. 44.
    Groh, V., A. Bruhl, H. El-Gabalawy, J.L. Nelson, and T. Spies. 2003. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Lewis L. Lanier
    • 1
  1. 1.Department of Microbiology and Immunology and the Cancer Research InstituteUniversity of California San FranciscoSan Francisco

Personalised recommendations